Laurent Pharmaceuticals is filling this crucial gap with LAU-7b, a broadly effective next-generation, host-directed, once-daily oral antiviral for the treatment of COVID-19 patients, with ...

Molnupiravir is the first oral antiviral treatment for Covid to report clinical trial results. An experimental drug for severe Covid cuts the risk of hospitalisation or death by about half ...

Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics. Several researchers at the University of ...

Molnupiravir is the first oral antiviral treatment for Covid to report clinical trial results. The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator.

The US government has already placed an order with Merck & Co to buy 1.7 million courses of its antiviral therapy molnupiravir for COVID-19, assuming it gets approved for use by the FDA, and Merck ...

[Reuters] A new program to provide oral antiviral treatments for Covid-19 in ten low- and middle-income countries has been launched. The initiative which will be a game changer in access to ...

The on-demand, online service will combine virtual consultations and next-day delivery of oral antiviral medicines – assuming those become available to patients in the US. Closest to emergency ...

Prescription antiviral medications are the first-line treatment for both oral and genital herpes. There’s no cure for herpes, ...

In December 2021, two oral antiviral medications received emergency use authorization (EUA) from the U.S. Food and Drug Administration for the treatment of patients with mild-to-moderate COVID-19.

A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed ... Japan is betting heavily on oral treatments to keep serious infections and deaths ...